CR
Live / Registered — Registered (as of 07 Mar 2023)
What this means for you
Registered since 07 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97124708
- Registration number
- 6994906
- Mark type
- Design + words
- Filed
- 15 Nov 2021
- Published for opposition
- 20 Dec 2022
- Registered
- 07 Mar 2023
- Attorney of record
- Nazly Aileen Bayramoglu
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Chemical reagents for medical or veterinary purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic preparations for medical purposes; Enzyme preparations for medical purposes; Stem cells for medical purposes; Stem cells for veterinary purposes; Surgical implants comprised of living tissues
Owner
- Corregene Biotechnology Co., Ltd, Beijing, CN
- Corregene Biotechnology Co., Ltd, Beijing, CN
- Corregene Biotechnology Co., Ltd, Beijing, CN
Prosecution history
- 07 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 20 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Dec 2022 — PUBLISHED FOR OPPOSITION
- 30 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Nov 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Oct 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Oct 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Oct 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Aug 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Aug 2022 — NON-FINAL ACTION E-MAILED
- 30 Aug 2022 — NON-FINAL ACTION WRITTEN
- 25 Aug 2022 — ASSIGNED TO EXAMINER
- 20 Nov 2021 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 19 Nov 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED